Evidence map›Paper›PMID 12388737›Full record

ArticleJournal of virology2002

The human cytomegalovirus US10 gene product delays trafficking of major histocompatibility complex class I molecules.

Margo H Furman, Neelendu Dey, Domenico Tortorella, Hidde L Ploegh

Abstract read
In one paragraph

Article in Journal of virology, 2002. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 52 papers.

0numbers the graph read from it
0cells of the map it votes in
52citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

52 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Article
  6. Viral MicroRNAs in Herpes Simplex Virus 1 Pathobiology.Current pharmaceutical design · 2024
    Review
  7. Review
  8. Article
  9. Review
  10. Article
  11. Review
  12. Review
  13. Article
  14. Review
  15. Battle between Host Immune Cellular Responses and HCMV Immune Evasion.International journal of molecular sciences · 2019
    Review
  16. Article
  17. Article
  18. Review
  19. Herpesviruses: Harmonious Pathogens but Relevant Cofactors in Other Diseases?Frontiers in cellular and infection microbiology · 2018
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Margo H FurmanDepartment of Pathology, Harvard Medical School, Boston, Massachusetts 02115, USA.
Neelendu Dey
Domenico Tortorella
Hidde L Ploegh

Funding

VIRAL EVASION STRATEGIES--ANALYSIS OF THE HERPES VIRUSES HSV,VZV, AND HHV 6 &7P01AI042257 · NIAID · IMMUNE DISEASE INSTITUTE, INC. · PI CARROLL, MICHAEL CRAIG · 1997 to 2000
$990k
NIAID NIH HHS P01 AI4225705
6 · The paper itself

Abstract

Human cytomegalovirus (HCMV) US10 encodes a glycoprotein that binds to major histocompatibility complex (MHC) class I heavy chains. While expression of US10 delays the normal trafficking of MHC class I molecules out of the endoplasmic reticulum, US10 does not obviously facilitate or inhibit the action of two other HCMV-encoded MHC class I binding proteins, US2 and US11.

Indexed as

Capsid ProteinsAntigen PresentationCapsidCytomegalovirusHistocompatibility Antigens Class IHumansPhosphoproteinsRNA-Binding ProteinsTransfectionTumor Cells, CulturedViral Envelope ProteinsViral ProteinsCapsid ProteinsHistocompatibility Antigens Class IPhosphoproteinsRNA-Binding ProteinsUS10 protein, Herpes simplex virus type 1US11 protein, herpesvirusUS2 protein, VaricellovirusViral Envelope ProteinsViral Proteins

Identifiers

PMID12388737
PMCPMC136774

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.